- Home
- RAAQ vs ALEC Comparison
RAAQ vs ALEC Comparison
Compare RAAQ & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$1.87
Company Overview
Basic Information| Metric | RAAQ | ALEC |
|---|---|---|
| Founded | 2024 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 234.6M | 193.2M |
| IPO Year | 2025 | 2019 |
Fundamental Metrics
Financial Performance| Metric | RAAQ | ALEC |
|---|---|---|
| Price | $10.36 | $1.87 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $3.33 |
| AVG Volume (30 Days) | 21.3K | ★ 1.2M |
| Earning Date | 01-01-0001 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $69,048,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 12.26 |
| 52 Week Low | $9.62 | $0.87 |
| 52 Week High | $10.83 | $3.40 |
Technical Indicators
Market Signals| Indicator | RAAQ | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 66.41 |
| Support Level | N/A | $1.74 |
| Resistance Level | N/A | $1.94 |
| Average True Range (ATR) | 0.00 | 0.11 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 0.00 | 76.26 |
Price Performance
Historical Comparison RAAQ
ALEC
About RAAQ Real Asset Acquisition Corp. Class A Ordinary Share
Real Asset Acquisition Corp is a blank check company.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.